PollyANiravathMD

Oncology • Houston, TX

Assistant Professor, Breast Center, Baylor College of Medicine

Join to view full profile

Dr. Niravath is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Niravath's full profile

Already have an account?

Office
6445 Main Street
OPC 24
Houston, TX 77030
Phone+1 713-441-9948

Fax+1 713-441-8791
Is this information wrong?

Education & Training

Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011
Baylor College of MedicineResidency, Internal Medicine, 2005 - 2008
University of California, Irvine, School of MedicineClass of 2005

Certifications & Licensure

TX State Medical License 2007 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer Start of enrollment: 2007 Dec 01
Completed
Phase 2
HKI-272 for HER2-Positive Breast Cancer and Brain Metastases Start of enrollment: 2012 Feb 01
Active, not recruiting
Phase 2
Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer Start of enrollment: 2013 Oct 01
Withdrawn
Phase 2
REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy Start of enrollment: 2013 Sep 01
Recruiting
Phase 2
Scalp Cooling to Prevent Chemo-induced Hair Loss Start of enrollment: 2014 May 15
Active, not recruiting
Not Applicable
High Dose Vitamin D vs Standard Dose Vitamin D Study Start of enrollment: 2013 Dec 01
Terminated
Phase 2
CRIZENT: Crizotinib and Sunitinib in Metastatic Breast Cancer Start of enrollment: 2014 Jun 01
Terminated
Phase 1
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC) Start of enrollment: 2023 Jan 12
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

3 citations
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer.
Kai Sun, Yitian Xu, Licheng Zhang, Polly Niravath, Jorge Darcourt, Tejal Patel, Bin S Teh, Andrew M Farach, Carlo Guerrero, Sunil Mathur, Mark A Sultenfuss, Nakul Gupt...> ;Clinical Cancer Research. 2022 Oct 14
1 citations
Clinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal metastases.
Akshjot Puri, Charisma Mylavarapu, Jiaqiong Xu, Tejal A Patel, Bin S Teh, Ivo Tremont-Lukats, Jenny C Chang, Polly Niravath> ;Breast Cancer Research and Treatment. 2022 Jun 1
39 citations
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer.
Andrew W Chung, Kartik Anand, Ann C Anselme, Alfred A Chan, Nakul Gupta, Luz A Venta, Mary R Schwartz, Wei Qian, Yitian Xu, Licheng Zhang, John Kuhn, Tejal Patel, Ange...> ;Science Translational Medicine. 2021 Dec 15
3 citations
Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration: Case Series and Review of Literature.
Mathew Chatham, Polly Niravath> ;Cureus. 2021 Dec 1
19 citations
A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractor...
Kartik Anand, Polly A. Niravath, Tejal Patel, Joe Ensor, Angel Rodriguez, Toniva Boone, Stephen T. C. Wong, Jenny C. Chang> ;Clinical Breast Cancer. 2021 Jun 1
5 citations
ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer
Emre Koca, Polly A. Niravath, Joe Ensor, Tejal Patel, Xiaoxian Li, Pej Hemati, Helen Wong, Wei Qian, Toniva Boone, Jing Zhao, Priya V. Ramshesh, Adam L. Cohen, Asha Mu...> ;Breast Cancer Research and Treatment. 2021 Apr 15
4 citations
Measuring Ovarian Escape in Premenopausal Estrogen Receptor-Positive Breast Cancer Patients on Ovarian Suppression Therapy
Ethan Burns, Emre Koca, Jiaqiong Xu, Edward T. McLean, Rosetta Lee, Tejal Patel, Jenny C. Chang, Polly A. Niravath> ;The Oncologist. 2021 Jun 1
14 citations
Targeting mTOR and DNA repair pathways in residual triple negative breast cancer post neoadjuvant chemotherapy.
Kartik Anand, Tejal Patel, Polly A. Niravath, Angel Rodriguez, Jorge Darcourt, Anna Belcheva, Toniva Boone, Joe Ensor, Jenny C. Chang> ;Scientific Reports. 2021 Jan 8
3 citations
The impact of HER2-directed targeted therapy on HER2-positive DCIS of the breast
Gary D. Lewis, Waqar Haque, Andrew M. Farach, Sandra S. Hatch, E. Brian Butler, Polly A. Niravath, Mary R. Schwartz, Elizabeth Bonefas, Bin S. Teh> ;Reports of Practical Oncology and Radiotherapy. 2021 Apr 14
1 citations
Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: a review of FDA Adverse Events Reporting System data.
Godsfavour Umoru, Matthew Taitano, Sarah Beshay, Polly A. Niravath, Sandeep Sahay> ;ERJ Open Research. 2020 Jul 20
31 citations
TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer.
Mothaffar F. Rimawi, Polly A. Niravath, Tao Wang, Brent N. Rexer, Andres Forero, Antonio C. Wolff, Rita Nanda, Anna Maria Storniolo, Ian E. Krop, Matthew P. Goetz, Jul...> ;Clinical Cancer Research. 2020 Feb 15
28 citations
Comparison of outcomes between metaplastic and triple-negative breast cancer patients.
Praveen Polamraju, Waqar Haque, Kevin Cao, Vivek Verma, Mary R. Schwartz, V. Suzanne Klimberg, Sandra S. Hatch, Polly A. Niravath, E. Brian Butler, Bin S. Teh> ;Breast. 2020 Feb 1
9 citations
Omission of radiation therapy following breast conservation in older (≥70 years) women with T1-2N0 triple-negative breast cancer.
Waqar Haque, Vivek Verma, Kuan Yin Hsiao, Sandra S. Hatch, Candy Arentz, Sean Szeja, Mary R. Schwartz, Polly A. Niravath, Elizabeth Bonefas, Darlene M. Miltenburg, Edw...> ;The Breast Journal. 2019 Nov 1
28 citations
A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-...
Tejal Patel, Joe Ensor, Sarah L. Creamer, Toniva Boone, Angel Rodriguez, Polly A. Niravath, Jorge Darcourt, Jane L. Meisel, Xiaoxian Li, Jing Zhao, John G. Kuhn, Rober...> ;Breast Cancer Research. 2019 Sep 2
5 citations
Acupuncture and Vitamin D for the Management of Aromatase Inhibitor-Induced Arthralgia.
Kartik Anand, Polly A. Niravath> ;Current Oncology Reports. 2019 Apr 17
220 citations
TBCRC 022: A phase II trial of neratinib and capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases
Rachel A. Freedman, Rebecca Gelman, Carey K. Anders, Michelle E. Melisko, Heather A. Parsons, Anne Cropp, Kelly Silvestri, Christine M Cotter, Kathryn P. Componeschi, ...> ;Journal of Clinical Oncology. 2019 Mar 12
12 citations
Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia
Polly A. Niravath, Susan G. Hilsenbeck, Tao Wang, Sao Jiralerspong, Julie R. Nangia, Anne Pavlick, Foluso O. Ademuyiwa, Ashley Frith, Cynthia X. Ma, Haeseong Park, Car...> ;Breast Cancer Research and Treatment. 2019 Jun 19
15 citations
A Behavior-Modification, Clinical-Grade Mobile Application to Improve Breast Cancer Survivors' Accountability and Health Outcomes.
Renee E. Stubbins, Tiancheng He, Xiaohui Yu, Mamta Puppala, Chika F. Ezeana, Shenyi Chen, Miguel Valdivia y Alvarado, Joe Ensor, Angel Rodriguez, Polly A. Niravath, Je...> ;JCO Clinical Cancer Informatics. 2018 Nov 30
8 citations
Treatment and Monitoring Patterns Among Premenopausal Women with HR+/HER2− Advanced Breast Cancer
Anand A. Dalal, Geneviève Gauthier, Patrick Gagnon-Sanschagrin, Rebecca Burne, Annie Guerin, Polly A. Niravath, Tania Small> ;Advances in Therapy. 2018 Aug 13
1 citations
Monitoring of Hematologic, Cardiac, and Hepatic Function in Post-Menopausal Women with HR+/HER2- Metastatic Breast Cancer
Annie Guerin, Debbie Goldschmidt, Tania Small, Patrick Gagnon-Sanschagrin, Hela Romdhani, Geneviève Gauthier, Sneha S. Kelkar, Eric Q. Wu, Polly A. Niravath, Anand A. ...> ;Advances in Therapy. 2018 Jun 26
9 citations
Progression-free survival with endocrine-based therapies following progression on non-steroidal aromatase inhibitor among postmenopausal women with hormone receptor po...
Rajeev Ayyagari, Derek H. Tang, Oscar Patterson-Lomba, Zhou Zhou, Jipan Xie, David Chandiwana, Anand A. Dalal, Polly A. Niravath> ;Current Medical Research and Opinion. 2018 Jun 12
9 citations
Dosing Patterns and Economic Burden of Palbociclib Drug Wastage in HR+/HER2− Metastatic Breast Cancer
Anand A. Dalal, Patrick Gagnon-Sanschagrin, Rebecca Burne, Annie Guerin, Geneviève Gauthier, Tania Small, Polly A. Niravath> ;Advances in Therapy. 2018 Jun 4
9 citations
Progression-free Survival With First-line Endocrine-based Therapies Among Postmenopausal Women With HR+/HER2- Metastatic Breast Cancer:: A Network Meta-analysis.
Rajeev Ayyagari, Derek H. Tang, Oscar Patterson-Lomba, Zhou Zhou, Jipan Xie, David Chandiwana, Anand A. Dalal, Polly A. Niravath> ;Clinical Therapeutics. 2018 Apr 1
8 citations
Current Treatment Patterns Among Postmenopausal Women with HR+/HER2− Metastatic Breast Cancer in US Community Oncology Practices: An Observational Study
Deborah Goldschmidt, Anand A. Dalal, Hela Romdhani, Sneha S. Kelkar, Annie Guerin, Geneviève Gauthier, Eric Q. Wu, Polly A. Niravath, Tania Small> ;Advances in Therapy. 2018 Apr 1
6 citations
Economic Burden of HR+/HER2- Metastatic Breast Cancer Among Adult Premenopausal Women
Geneviève Gauthier, Patrick Gagnon-Sanschagrin, Annie Guerin, Rebecca Burne, Tania Small, Polly A. Niravath, Anand A. Dalal> ;Advances in Therapy. 2018 Mar 20
Join now to see all

Lectures

Current Treatment Strategies for Metastatic Breast Cancer
2013 International Symposium, San Antonio, Texas, USA
Current Treatment Strategies for Metastatic Breast Cancer
San Antonio Breast Cancer Symposium, 2013 International Symposium, San Antonio, Texas, USA

Press Mentions

The Eating and Drinking Habits That Affect Your Breast Cancer RiskOctober 11th, 2022
The Eating and Drinking Habits That Affect Your Risk of Breast CancerOctober 11th, 2022
Study Shows the Pain of Carrying Debt Can Be Physical, TooOctober 4th, 2021
Join now to see all